🟢 Cue Biopharma is trading 5.86% up today with no verified company-specific catalyst

Cue Biopharma is trading 5.86% up at $32.90, with no verified company-specific announcement dated August 14, 2026 identified.

• The latest official company release remains the August 3 CFO appointment and CUE-221 IND update.
• An August 12 SEC S-3 filing was reported, but no evidence directly explains the move.
• The broader market is only modestly higher; volume and activity level were unavailable from reliable sources, and the rally cannot be confidently attributed to market-wide momentum.